BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Yoo GS, Yu JI, Park HC. Proton therapy for hepatocellular carcinoma: Current knowledges and future perspectives. World J Gastroenterol 2018; 24(28): 3090-3100 [PMID: 30065555 DOI: 10.3748/wjg.v24.i28.3090]
URL: https://www.wjgnet.com/1948-5182/full/v24/i28/3090.htm
Number Citing Articles
David Brasse, Hélène Burckel, Patrice Marchand, Marc Rousseau, Ali Ouadi, Marie Vanstalle, Christian Finck, Patrice Laquerriere, Frédéric Boisson. Comparison of the [18F]-FDG and [18F]-FLT PET Tracers in the Evaluation of the Preclinical Proton Therapy Response in Hepatocellular CarcinomaMolecular Imaging and Biology 2021; 23(5): 724 doi: 10.1007/s11307-021-01602-3
Gitanjali Bajaj, Karthik Sundaram, Kedar Jambhekar, Roopa Ram. Imaging After Locoregional Therapy for Hepatocellular Carcinoma with Emphasis on LIRADS Treatment Response Assessment CriteriaSeminars in Ultrasound, CT and MRI 2021; 42(4): 318 doi: 10.1053/j.sult.2021.04.004
Gagan Saini, Rashmi Shukla, Kanika S. Sood, Sujit K. Shukla, Ritu Chandra. Role of Proton Beam Therapy in Current Day Radiation Oncology PracticeAsian Journal of Oncology 2020; 6(03): 097 doi: 10.1055/s-0040-1713703
Gyu Sang Yoo, Jeong Il Yu, Hee Chul Park, Dongho Hyun, Woo Kyoung Jeong, Ho Yeong Lim, Moon Seok Choi, Sang Yun Ha. Do Biliary Complications after Proton Beam Therapy for Perihilar Hepatocellular Carcinoma Matter?Cancers 2020; 12(9): 2395 doi: 10.3390/cancers12092395
Kyung Su Kim, Hong-Gyun Wu. Who Will Benefit from Charged-Particle Therapy?Cancer Research and Treatment 2021; 53(3): 621 doi: 10.4143/crt.2021.299
Gyu Sang Yoo, Won-Gyun Ahn, Shin-Yeong Kim, Wonseok Kang, Changhoon Choi, Hee Chul Park. Radiation-induced abscopal effect and its enhancement by programmed cell death 1 blockade in the hepatocellular carcinoma: A murine model studyClinical and Molecular Hepatology 2021; 27(1): 144 doi: 10.3350/cmh.2020.0095
Beau B. Toskich, Ryan E. Bailey, Sadeer J. Alzubaidi, Zlatko Devcic, Gregory T. Frey, Andrew R. Lewis, Michael R. Moynagh, Kabir Mody, Charles A. Ritchie, Terence T. Sio, Tushar Patel, Ricardo Paz-Fumagalli. Advances in the Ablative Management of Hepatocellular CarcinomaAdvances in Clinical Radiology 2019; 1: 215 doi: 10.1016/j.yacr.2019.04.007
Shu Xing, Jungwook Shin, Jennifer Pursley, Camilo M Correa-Alfonso, Nicolas Depauw, Sean Domal, Julia Withrow, Wesley Bolch, Clemens Grassberger, Harald Paganetti. A dynamic blood flow model to compute absorbed dose to circulating blood and lymphocytes in liver external beam radiotherapyPhysics in Medicine & Biology 2022; 67(4): 045010 doi: 10.1088/1361-6560/ac4da4
Gyu Sang Yoo, Jeong Il Yu, Sungkoo Cho, Sang Hoon Jung, Youngyih Han, Seyjoon Park, Yoonjin Oh, Boram Lee, Hee Chul Park, Do Hoon Lim, Moon Seok Choi, Hojeong Won. Comparison of clinical outcomes between passive scattering versus pencil-beam scanning proton beam therapy for hepatocellular carcinomaRadiotherapy and Oncology 2020; 146: 187 doi: 10.1016/j.radonc.2020.02.019
Chien Peter Chen. Role of External Beam Radiotherapy in Hepatocellular CarcinomaClinics in Liver Disease 2020; 24(4): 701 doi: 10.1016/j.cld.2020.07.006
Shirley Lewis, Laura Dawson, Aisling Barry, Teodor Stanescu, Issa Mohamad, Ali Hosni. Stereotactic body radiation therapy for hepatocellular carcinoma: From infancy to ongoing maturityJHEP Reports 2022; 4(8): 100498 doi: 10.1016/j.jhepr.2022.100498
Hiroaki Takahashi, Yuta Sekino, Kensaku Mori, Toshiyuki Okumura, Katsuhiro Nasu, Kuniaki Fukuda, Sota Masuoka, Takashi Iizumi, Naoyuki Hasegawa, Hideyuki Sakurai, Manabu Minami. Indicator for local recurrence of hepatocellular carcinoma after proton beam therapy: analysis of attenuation difference between the irradiated tumor and liver parenchyma on contrast enhancement CTThe British Journal of Radiology 2020; 93(1105): 20190375 doi: 10.1259/bjr.20190375
Esben Schjødt Worm, Rune Hansen, Morten Høyer, Britta Weber, Hanna Mortensen, Per Rugaard Poulsen. Uniform versus non-uniform dose prescription for proton stereotactic body radiotherapy of liver tumors investigated by extensive motion-including treatment simulationsPhysics in Medicine & Biology 2021; 66(20): 205009 doi: 10.1088/1361-6560/ac2880
Hiroaki Takahashi, Kensaku Mori, Yuta Sekino, Toshiyuki Okumura, Takashi Hiyama, Kuniaki Fukuda, Naoyuki Hasegawa, Masafumi Sakai, Shunsuke Kikuchi, Yohei Takei, Takashi Iizumi, Hideyuki Sakurai, Manabu Minami. Angiographic Findings in Patients with Hepatocellular Carcinoma Previously Treated Using Proton Beam TherapyJournal of Oncology 2019; 2019: 1 doi: 10.1155/2019/3580379
Tai-Ze Yuan, Ze-Jiang Zhan, Chao-Nan Qian. New frontiers in proton therapy: applications in cancersCancer Communications 2019; 39(1): 61 doi: 10.1186/s40880-019-0407-3
Suresh Subramanian, Madhava B. Mallia, Ajit S. Shinto, Ashwathy S. Mathew. Clinical Management of Liver Cancer in India and Other Developing Nations: A Focus on Radiation Based StrategiesOncology and Therapy 2021; 9(2): 273 doi: 10.1007/s40487-021-00154-4
Dmitry Dzhuzha. Charged particles therapy in radiation oncologyRadiation Diagnostics, Radiation Therapy 2020; (1): 39 doi: 10.37336/2707-0700-2020-1-4
Yu-Lun Tsai, Hideyuki Takei, Takashi Iizumi, Toshiyuki Okumura, Yuta Sekino, Haruko Numajiri, Hitoshi Ishikawa, Takeji Sakae, Hideyuki Sakurai. Capacity of proton beams in preserving normal liver tissue during proton beam therapy for hepatocellular carcinomaJournal of Radiation Research 2021; 62(1): 133 doi: 10.1093/jrr/rraa098
Jana M. Kobeissi, Lara Hilal, Charles B. Simone, Haibo Lin, Christopher H. Crane, Carla Hajj. Proton Therapy in the Management of Hepatocellular CarcinomaCancers 2022; 14(12): 2900 doi: 10.3390/cancers14122900
So-Young Chun, Kyung-Soo Nam, Kyu-Shik Lee. Proton Beam Induces P53-mediated Cell Cycle Arrest in HepG2 Hepatocellular Carcinoma CellsBiotechnology and Bioprocess Engineering 2020; 25(2): 141 doi: 10.1007/s12257-019-0390-1
Boram Lee, Sungkoo Cho, Hee Chul Park, Sang-Won Kang, Jae-Sung Kim, Jin-Beom Chung. Assessment of dose perturbations for metal stent in photon and proton radiotherapy plans for hepatocellular carcinomaRadiation Oncology 2022; 17(1) doi: 10.1186/s13014-022-02100-8
Changhoon Choi, Arang Son, Ga-Haeng Lee, Sung-Won Shin, Sohee Park, Sang Hee Ahn, Yoonsun Chung, Jeong Il Yu, Hee Chul Park, Yi-Hsien Hsieh. Targeting DNA-dependent protein kinase sensitizes hepatocellular carcinoma cells to proton beam irradiation through apoptosis inductionPLOS ONE 2019; 14(6): e0218049 doi: 10.1371/journal.pone.0218049
Chien Pong Chen. Role of Radiotherapy in the Treatment of Hepatocellular CarcinomaJournal of Clinical and Translational Hepatology 2019; 7(X): 1 doi: 10.14218/JCTH.2018.00060
Jen-Yu Cheng, Chieh-Min Liu, Yu-Ming Wang, Hsuan-Chih Hsu, Eng-Yen Huang, Tzu-Ting Huang, Ching-Hsin Lee, Sheng-Ping Hung, Bing-Shen Huang. Proton versus photon radiotherapy for primary hepatocellular carcinoma: a propensity-matched analysisRadiation Oncology 2020; 15(1) doi: 10.1186/s13014-020-01605-4
Changhoon Choi, Gyu Sang Yoo, Won Kyung Cho, Hee Chul Park. Optimizing radiotherapy with immune checkpoint blockade in hepatocellular carcinomaWorld Journal of Gastroenterology 2019; 25(20): 2416-2429 doi: 10.3748/wjg.v25.i20.2416
Jihye Kim, Gyu Sang Yoo, Dong Hyun Sinn, Hee Chul Park, Kwang Cheol Koh. Radiation-induced Myositis after Proton Beam Therapy to Huge Hepatocellular CarcinomaJournal of Liver Cancer 2019; 19(2): 136 doi: 10.17998/jlc.19.2.136
Wenxiu Zhao, Xiaobin Jiang, Karrin Weisenthal, Jun Ma, Erin M. Botticelli, Yunli Zhou, E. Tessa Hedley-Whyte, Baiyao Wang, Brooke Swearingen, Roy J. Soberman, Anne Klibanski, Xun Zhang. High Histone Deacetylase 2/3 Expression in Non-Functioning Pituitary TumorsFrontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.875122
Jing Yang, Jiali Wang, Jialin Luo. Decreased IL-6 induces sensitivity of hepatocellular carcinoma cells to sorafenibPathology - Research and Practice 2019; 215(10): 152565 doi: 10.1016/j.prp.2019.152565
Bong Kyung Bae, Hee Chul Park, Jeong Il Yu, Gyu Sang Yoo, Dong Hyun Sinn, Moon Seok Choi, Joo Hyun Oh. Trends in radiotherapy administration in the management of hepatocellular carcinoma: Analysis of a Korean tertiary hospital registry of hepatocellular carcinoma patients diagnosed between 2005 and 2017Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.928119